TOP
Are you on track with insurance advances? Find out with Spotlights!
Obesity is a chronic condition that requires long-term management. It goes along with clinical complications that affect almost every organ system. Recently, the glucagon-like peptide 1 (GLP‑1) analogue semaglutide was approved as an official weight loss medication.
This webinar discusses the effects of GLP‑1 analogues, compares them to the outcome of bariatric surgery, and evaluates the implications of weight loss for medical risk assessment.
Look into the future with Gen Re!
Target group: Underwriters, claims assessors, product developers, actuaries and other interested employees in Life/Health insurance
Location: Online webinar
Seminar fee: Free for Gen Re clients
Registration: Please get in touch with your local Gen Re contact
Anke Siebers joined the Gen Re Business School in 2005. As an Insurance Education Consultant, she is responsible for the international Business School seminars, webinars and publications in Life/Health underwriting and claims. Being a psychologist, Anke has a professional core interest in mental health topics and a personal passion for international projects.
Do you have any questions? Please don’t hesitate to get in touch with us.
